{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:54:32Z","timestamp":1790391272476,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["201492\/Z\/16\/Z"],"award-info":[{"award-number":["201492\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R025223\/1"],"award-info":[{"award-number":["MR\/R025223\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020560","name":"South East Regional Health Authority","doi-asserted-by":"publisher","award":["#2020023, #2019097"],"award-info":[{"award-number":["#2020023, #2019097"]}],"id":[{"id":"10.13039\/501100020560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S021949\/1"],"award-info":[{"award-number":["MR\/S021949\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Health-related quality of life metrics evaluate treatments in ways that matter to patients, so are often included in randomised clinical trials (hereafter trials). Multimorbidity, where individuals have 2 or more conditions, is negatively associated with quality of life. However, whether multimorbidity predicts change over time or modifies treatment effects for quality of life is unknown. Therefore, clinicians and guideline developers are uncertain about the applicability of trial findings to people with multimorbidity. We examined whether comorbidity count (higher counts indicating greater multimorbidity) (i) is associated with quality of life at baseline; (ii) predicts change in quality of life over time; and\/or (iii) modifies treatment effects on quality of life.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and findings<\/jats:title>\n<jats:p>Included trials were registered on the United States trials registry for selected index medical conditions and drug classes, phase 2\/3, 3 or 4, had \u2265300 participants, a nonrestrictive upper age limit, and were available on 1 of 2 trial repositories on 21 November 2016 and 18 May 2018, respectively. Of 124 meeting these criteria, 56 trials (33,421 participants, 16 index conditions, and 23 drug classes) collected a generic quality of life outcome measure (35 EuroQol-5 dimension (EQ-5D), 31 36-item short form survey (SF-36) with 10 collecting both). Blinding and completeness of follow up were examined for each trial.<\/jats:p>\n<jats:p>Using trials where individual participant data (IPD) was available from 2 repositories, a comorbidity count was calculated from medical history and\/or prescriptions data. Linear regressions were fitted for the association between comorbidity count and (i) quality of life at baseline; (ii) change in quality of life during trial follow up; and (iii) treatment effects on quality of life. These results were then combined in Bayesian linear models. Posterior samples were summarised via the mean, 2.5th and 97.5th percentiles as credible intervals (95% CI) and via the proportion with values less than 0 as the probability (P<jats:sub>Bayes<\/jats:sub>) of a negative association.<\/jats:p>\n<jats:p>All results are in standardised units (obtained by dividing the EQ-5D\/SF-36 estimates by published population standard deviations). Per additional comorbidity, adjusting for age and sex, across all index conditions and treatment comparisons, comorbidity count was associated with lower quality of life at baseline and with a decline in quality of life over time (EQ-5D \u22120.02 [95% CI \u22120.03 to \u22120.01], P<jats:sub>Bayes<\/jats:sub> &gt; 0.999). Associations were similar, but with wider 95% CIs crossing the null for SF-36-PCS and SF-36-MCS (\u22120.05 [\u22120.10 to 0.01], P<jats:sub>Bayes<\/jats:sub> = 0.956 and \u22120.05 [\u22120.10 to 0.01], P<jats:sub>Bayes<\/jats:sub> = 0.966, respectively). Importantly, there was no evidence of any interaction between comorbidity count and treatment efficacy for either EQ-5D or SF-36 (EQ-5D \u22120.0035 [95% CI \u22120.0153 to \u22120.0065], P<jats:sub>Bayes<\/jats:sub> = 0.746; SF-36-MCS (\u22120.0111 [95% CI \u22120.0647 to 0.0416], P<jats:sub>Bayes<\/jats:sub> = 0.70 and SF-36-PCS \u22120.0092 [95% CI \u22120.0758 to 0.0476], P<jats:sub>Bayes<\/jats:sub> = 0.631.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Treatment effects on quality of life did not differ by multimorbidity (measured via a comorbidity count) at baseline\u2014for the medical conditions studied, types and severity of comorbidities and level of quality of life at baseline, suggesting that evidence from clinical trials is likely to be applicable to settings with (at least modestly) higher levels of comorbidity.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>A prespecified protocol was registered on PROSPERO (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42018048202\" xlink:type=\"simple\">CRD42018048202<\/jats:ext-link>).<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pmed.1004154","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T18:28:41Z","timestamp":1673980121000},"page":"e1004154","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9410-0237","authenticated-orcid":true,"given":"Elaine W.","family":"Butterly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5828-3934","authenticated-orcid":true,"given":"Peter","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2825-3419","authenticated-orcid":true,"given":"Anoop S. V.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3123-5411","authenticated-orcid":true,"given":"Laurie J.","family":"Hannigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Lewsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7824-2569","authenticated-orcid":true,"given":"Sarah H.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4191-4880","authenticated-orcid":true,"given":"Bruce","family":"Guthrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances S.","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-0221","authenticated-orcid":true,"given":"Sofia","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky J.","family":"Welton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3550-1764","authenticated-orcid":true,"given":"David A.","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"pmed.1004154.ref001","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1525-1497.1999.00354.x","article-title":"What Outcomes Matter to Patients","volume":"14","author":"CD Sherbourne","year":"1999","journal-title":"J Gen Intern Med"},{"key":"pmed.1004154.ref002","unstructured":"EQ-5D User Guides\u2013EQ-5D. [cited 2021 Nov 19]. Available from: https:\/\/euroqol.org\/publications\/user-guides\/."},{"key":"pmed.1004154.ref003","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 Health Survey Update","volume":"25","author":"JEJ Ware","year":"2000","journal-title":"Spine"},{"key":"pmed.1004154.ref004","doi-asserted-by":"crossref","first-page":"e0187825","DOI":"10.1371\/journal.pone.0187825","article-title":"Predicting mortality and hospitalization of older adults by the multimorbidity frailty index","volume":"12","author":"Y-C Wen","year":"2017","journal-title":"PLoS ONE"},{"key":"pmed.1004154.ref005","article-title":"Assessing trial representativeness using Serious Adverse Events: An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data","author":"P Hanlon","year":"2022","journal-title":"BMC Med"},{"key":"pmed.1004154.ref006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1741-7015-11-263","article-title":"Multimorbidity in bipolar disorder and undertreatment of cardiovascular disease: a cross sectional study.","volume":"11","author":"DJ Smith","year":"2013","journal-title":"BMC Med"},{"issue":"46","key":"pmed.1004154.ref007","first-page":"273","article-title":"Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives","volume":"2005","author":"PS Wang","year":"1979","journal-title":"Hypertens Dallas Tex"},{"key":"pmed.1004154.ref008","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12955-019-1180-3","article-title":"Health related quality of life in multimorbidity: a primary-care based study from Odisha.","volume":"17","author":"S Pati","year":"2019","journal-title":"India Health Qual Life Outcomes"},{"key":"pmed.1004154.ref009","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1477-7525-5-52","article-title":"Multimorbidity and quality of life: a closer look","volume":"5","author":"M Fortin","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"pmed.1004154.ref010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7525-2-51","article-title":"Multimorbidity and quality of life in primary care: a systematic review.","volume":"2","author":"M Fortin","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"pmed.1004154.ref011","doi-asserted-by":"crossref","first-page":"e66742","DOI":"10.1371\/journal.pone.0066742","article-title":"Relative Impact of Multimorbid Chronic Conditions on Health-Related Quality of Life\u2013Results from the MultiCare Cohort Study","volume":"8","author":"C Brettschneider","year":"2013","journal-title":"PLoS ONE"},{"key":"pmed.1004154.ref012","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s11136-015-0995-6","article-title":"The added effect of comorbidity on health-related quality of life in patients with asthma.","volume":"24","author":"W Chen","year":"2015","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"pmed.1004154.ref013","doi-asserted-by":"crossref","first-page":"e040286","DOI":"10.1136\/bmjopen-2020-040286","article-title":"Health-related quality of life, functional impairment and comorbidity in people with mild-to-moderate chronic kidney disease: a cross-sectional study","volume":"10","author":"SD Fraser","year":"2020","journal-title":"BMJ Open"},{"key":"pmed.1004154.ref014","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3390\/medicina58010126","article-title":"Comorbidities and Health-Related Quality of Life in Subjects with Spine Osteoarthritis at 50 Years of Age or Older: Data from the Korea National Health and Nutrition Examination Survey.","volume":"58","author":"S-K Kim","year":"2022","journal-title":"Medicina (Kaunas)."},{"key":"pmed.1004154.ref015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1378\/chest.129.2.285","article-title":"Coexistent chronic conditions and asthma quality of life: a population-based study","volume":"129","author":"RJ Adams","year":"2006","journal-title":"Chest"},{"key":"pmed.1004154.ref016","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2196\/jmir.4143","article-title":"Multiple comorbidities of 21 psychological disorders and relationships with psychosocial variables: a study of the online assessment and diagnostic system within a web-based population","volume":"17","author":"AM Al-Asadi","year":"2015","journal-title":"J Med Internet Res"},{"key":"pmed.1004154.ref017","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12955-018-1063-z","article-title":"Measurement of health-related quality by multimorbidity groups in primary health care.","volume":"17","author":"M Mill\u00e1-Perseguer","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"pmed.1004154.ref018","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ageing\/afy155","article-title":"The impact of co-morbidity on the quality of life of people with dementia: findings from the IDEAL study","volume":"48","author":"SM Nelis","year":"2019","journal-title":"Age Ageing"},{"key":"pmed.1004154.ref019","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2165\/11586840-000000000-00000","article-title":"The impact of co-morbidity burden on preference-based health-related quality of life in the United States","volume":"30","author":"PW Sullivan","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"pmed.1004154.ref020","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11764-013-0299-1","article-title":"The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry","volume":"7","author":"PAJ Vissers","year":"2013","journal-title":"J Cancer Surviv Res Pract"},{"key":"pmed.1004154.ref021","doi-asserted-by":"crossref","first-page":"100903","DOI":"10.1016\/j.arr.2019.04.005","article-title":"Multimorbidity and quality of life: Systematic literature review and meta-analysis.","volume":"53","author":"TT Makovski","year":"2019","journal-title":"Ageing Res Rev"},{"key":"pmed.1004154.ref022","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s40273-019-00843-z","article-title":"Bayesian Hierarchical Models for Meta-Analysis of Quality-of-Life Outcomes: An Application in Multimorbidity.","volume":"38","author":"S Schmitz","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"pmed.1004154.ref023","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1370\/afm.2178","article-title":"A Core Outcome Set for Multimorbidity Research (COSmm).","volume":"16","author":"SM Smith","year":"2018","journal-title":"Ann Fam Med"},{"key":"pmed.1004154.ref024","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/pcan.2010.33","article-title":"From bad to worse: comorbidity severity and quality of life after treatment for early-stage prostate cancer","volume":"13","author":"TJ Daskivich","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"pmed.1004154.ref025","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1093\/rheumatology\/keaa841","article-title":"Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial.","volume":"60","author":"V Stouten","year":"2021","journal-title":"Rheumatology (Oxford)."},{"key":"pmed.1004154.ref026","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.otohns.2008.05.027","article-title":"The effect of comorbidity on quality of life during radiotherapy in head and neck cancer","volume":"139","author":"NB Oozeer","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"pmed.1004154.ref027","doi-asserted-by":"crossref","first-page":"e047812","DOI":"10.1136\/bmjopen-2020-047812","article-title":"Effect of multimorbidity patterns on the decline in health-related quality of life: a nationwide prospective cohort study in Japan.","volume":"11","author":"T Aoki","year":"2021","journal-title":"BMJ Open"},{"key":"pmed.1004154.ref028","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/17453674.2018.1457885","article-title":"Is gain in health-related quality of life after a total hip arthroplasty depended on the comorbidity burden?","volume":"89","author":"EN Glassou","year":"2018","journal-title":"Acta Orthop"},{"key":"pmed.1004154.ref029","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1007\/s11136-016-1282-x","article-title":"Predictors of health-related quality of life in people with a complex chronic disease including multimorbidity: a longitudinal cohort study","volume":"25","author":"Z Tyack","year":"2016","journal-title":"Qual Life Res"},{"key":"pmed.1004154.ref030","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12916-019-1427-1","article-title":"Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis","volume":"17","author":"P Hanlon","year":"2019","journal-title":"BMC Med"},{"key":"pmed.1004154.ref031","first-page":"1","article-title":"Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3\/4 industry funded clinical trials","author":"JS Lees","year":"2022","journal-title":"BMJ Med"},{"key":"pmed.1004154.ref032","unstructured":"Prospero registration. [cited 2022 Feb 22]. Available from: https:\/\/www.crd.york.ac.uk\/PROSPERO\/display_record.php?ID=CRD42018048202&ID=CRD42018048202."},{"key":"pmed.1004154.ref033","unstructured":"Home\u2014ClinicalTrials.gov. [cited 2020 Jul 1]. Available from: https:\/\/clinicaltrials.gov\/."},{"key":"pmed.1004154.ref034","unstructured":"WHOCC\u2014ATC\/DDD Index. [cited 2022 Feb 22]. Available from: https:\/\/www.whocc.no\/atc_ddd_index\/."},{"key":"pmed.1004154.ref035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-021-00029-9","article-title":"An analysis of frailty and multimorbidity in 20,566 UK Biobank participants with type 2 diabetes","volume":"1","author":"P Hanlon","year":"2021","journal-title":"Commun Med"},{"key":"pmed.1004154.ref036","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.publhealth.21.1.587","article-title":"Preference-based measures in economic evaluation in health care","volume":"21","author":"PJ Neumann","year":"2000","journal-title":"Annu Rev Public Health"},{"key":"pmed.1004154.ref037","unstructured":"Valuation of EQ-5D \u2013EQ-5D. [cited 2022 Oct 14]. Available from: https:\/\/euroqol.org\/eq-5d-instruments\/valuation-of-eq-5d\/."},{"key":"pmed.1004154.ref038","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1023\/A:1012552211996","article-title":"Do SF-36 Summary Component Scores Accurately Summarize Subscale Scores?","volume":"10","author":"C Taft","year":"2001","journal-title":"Qual Life Res"},{"key":"pmed.1004154.ref039","volume-title":"Centre for Health Economics","author":"University of York","year":"1999"},{"key":"pmed.1004154.ref040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12955-017-0625-9","article-title":"Measurement properties and normative data for the Norwegian SF-36: results from a general population survey","volume":"15","author":"AM Garratt","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"pmed.1004154.ref041","article-title":"brms: An R Package for Bayesian Multilevel Models Using Stan","journal-title":"J Stat Softw"},{"key":"pmed.1004154.ref042","unstructured":"Anonymisation of Clinical Trial Datasets. Available from: https:\/\/clinicalstudydatarequest.com\/Documents\/Anonymisation%20of%20Clinical%20Trial%20Datasets.pdf."},{"key":"pmed.1004154.ref043","unstructured":"Overview | Multimorbidity: clinical assessment and management | Guidance | NICE. [cited 2022 Oct 14]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng56."},{"key":"pmed.1004154.ref044","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12916-019-1427-1","article-title":"Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis","volume":"17","author":"P Hanlon","year":"2019","journal-title":"BMC Med"},{"key":"pmed.1004154.ref045","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0149-2918(00)88295-8","article-title":"Effects of comorbidity on health-related quality-of-life scores: an analysis of clinical trial data.","volume":"21","author":"J Xuan","year":"1999","journal-title":"Clin Ther"},{"key":"pmed.1004154.ref046","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0272989X13487604","article-title":"Evidence Synthesis for Decision Making 1: Introduction","volume":"33","author":"S Dias","year":"2013","journal-title":"Med Decis Making"},{"key":"pmed.1004154.ref047","doi-asserted-by":"crossref","first-page":"g6680","DOI":"10.1136\/bmj.g6680","article-title":"Thinking about the burden of treatment","volume":"349","author":"FS Mair","year":"2014","journal-title":"BMJ"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T18:29:18Z","timestamp":1673980158000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004154","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]}}}